From Health Canada:
ARAVA (leflunomide) and interstitial lung disease
Cases of lung inflammation causing difficulty breathing have occurred rarely in patients receiving Arava®. Tell your doctor without delay if you experience new or worsening of shortness of breath and/or cough, with or without associated fever, at any time while you are taking Arava®.
Thursday, July 08, 2004
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment